MoneyWorks4Me

Balaxi Pharma. - Quaterly Results

23 May 2022 Evaluate
A decrease in the sales to Rs. 206.47 millions was observed for the quarter ended March 2022. The sales stood at Rs. 225.97 millions during the similar quarter previous year.Net profit stood at Rs. 35.27  millions  compared to Rs. 31.60 millions in the corresponding previous quarter,high by 11.61%.The company reported a good operating profit of 49.76 millions compared to 46.34 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 206.47 225.97 -8.63 1012.92 868.71 16.60 1012.92 868.71 16.60
Other Income 10.71 0.43 2390.70 27.48 18.10 51.82 27.48 18.10 51.82
PBIDT 49.76 46.34 7.38 200.10 206.98 -3.32 200.10 206.98 -3.32
Interest 0.21 0.04 425.00 0.61 0.13 369.23 0.61 0.13 369.23
PBDT 49.55 46.30 7.02 199.49 206.85 -3.56 199.49 206.85 -3.56
Depreciation 0.78 0.24 225.00 2.50 0.88 184.09 2.50 0.88 184.09
PBT 48.77 46.06 5.88 196.99 205.97 -4.36 196.99 205.97 -4.36
TAX 13.50 14.46 -6.64 50.32 54.64 -7.91 50.32 54.64 -7.91
Deferred Tax 0.07 0.01 600.00 0.32 0.04 700.00 0.32 0.04 700.00
PAT 35.27 31.60 11.61 146.67 151.33 -3.08 146.67 151.33 -3.08
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 100.00 0.00
PBIDTM(%) 24.10 20.51 17.52 19.75 23.83 -17.09 19.75 23.83 -17.09
Peers